Oncology
Healthscope Molecular is developing a growing range of molecular tests to aid in the detection of cancer and improved prescribing of oncology drugs.
Our HPV test is the most advanced in Australia and was developed in collaboration with Genera BioSystems.
We have just released a pharmacogenomic test for Tamoxifen to assist in not only avoiding ADR, but also to ensure that the optimum dose and frequency is prescribed first time.
Through Healthscope Molecular’s cytogentics service, we offer a comprehensive service to aid the diagnosis and prognosis of cancer.
We are looking to expand test range to include cancer markers.